Literature DB >> 10412737

Effect of lipoproteins on mesangial cell proliferation.

Y Nishida1, H Oda, N Yorioka.   

Abstract

BACKGROUND: Triglyceride (TG)-rich lipoproteins have been reported to promote atherosclerosis, but little is known about their role in kidney disease or about their effects on mesangial cells. Accordingly, the purpose of this study was to investigate which lipoproteins could influence mesangial cell proliferation in vitro. We assessed the effect of various lipoproteins [very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), low density lipoprotein (LDL), oxidized LDL, and high-density lipoprotein (HDL)] on the proliferation of cultured human mesangial cells and also assessed the influence of these lipoproteins on cytokine production.
METHODS: We investigated the effect of various lipoproteins on cultured human mesangial cells using 3H-thymidine incorporation and cell counting assays and investigated the levels of several cytokines [interleukin (IL)-6, platelet-derived growth factor (PDGF), transforming growth factor (TGF)-beta, and tumor necrosis factor-alpha] in mesangial cell culture supernatants after stimulation by the lipoproteins.
RESULTS: Not only LDL but also TG-rich lipoproteins (VLDL and IDL) promoted the proliferation of mesangial cells up to certain concentrations, but cell growth was actually decreased at higher concentrations. Oxidized LDL caused a concentration-dependent decrease of 3H-thymidine incorporation, and HDL had no proliferative effect at any concentration. Exposure to VLDL, IDL, LDL, or a high concentration of HDL enhanced the secretion of IL-6, PDGF-AB, and TGF-beta by mesangial cells, whereas TNF-alpha secretion was stimulated by oxidized LDL.
CONCLUSIONS: TG-rich lipoproteins, LDL, and oxidized LDL may be involved in mesangial cell proliferation and injury in patients with mesangial proliferative glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412737     DOI: 10.1046/j.1523-1755.1999.07113.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  14 in total

1.  Exposure to oxidized low-density lipoprotein reduces activable Ras protein in vascular endothelial cells.

Authors:  Shu-Er Chow; Wing-Keung Chu; Stephen H Shih; Jan-Kan Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-06       Impact factor: 2.416

Review 2.  Dyslipidemia in patients with chronic and end-stage kidney disease.

Authors:  Jad Omran; Ashraf Al-Dadah; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2013-07-13       Impact factor: 2.041

Review 3.  Bariatric surgery and renal function.

Authors:  Andrew Currie; Andrew Chetwood; Ahmed R Ahmed
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

Review 4.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

5.  Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.

Authors:  Chelsea Corradetti; Neelakshi R Jog; Matteo Cesaroni; Michael Madaio; Roberto Caricchio
Journal:  J Immunol       Date:  2017-12-13       Impact factor: 5.422

6.  Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Xinyu Qi; Heather Norman; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

Review 7.  Impact of treating the metabolic syndrome on chronic kidney disease.

Authors:  Varun Agrawal; Aashish Shah; Casey Rice; Barry A Franklin; Peter A McCullough
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

Review 8.  An update on the lipid nephrotoxicity hypothesis.

Authors:  Xiong Z Ruan; Zac Varghese; John F Moorhead
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

9.  A computational model of flow and species transport in the mesangium.

Authors:  Sarah E Hunt; Kevin D Dorfman; Yoav Segal; Victor H Barocas
Journal:  Am J Physiol Renal Physiol       Date:  2015-10-14

10.  Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry.

Authors:  Andrea O Y Luk; Wing-Yee So; Ronald C W Ma; Alice P S Kong; Risa Ozaki; Vanessa S W Ng; Linda W L Yu; Winnie W Y Lau; Xilin Yang; Francis C C Chow; Juliana C N Chan; Peter C Y Tong
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.